Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis

Mycophenolate mofetil (MMF) is an immunosuppressive agent (IS) which is widely prescribed in neuromyelitis optica spectrum disorder (NMOSD) patients. We aim to assess the efficacy and safety of MMF in controlling relapse and disease severity. Eligible studies obtained from the EMBASE and Ovid MEDLIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Songwisit, Sakdipat, Kosiyakul, Punchika, Jitprapaikulsan, Jiraporn, Prayoonwiwat, Naraporn, Ungprasert, Patompong, Siritho, Sasitorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541495/
https://www.ncbi.nlm.nih.gov/pubmed/33028926
http://dx.doi.org/10.1038/s41598-020-73882-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541495/
https://www.ncbi.nlm.nih.gov/pubmed/33028926
http://dx.doi.org/10.1038/s41598-020-73882-8

Ejemplares similares